Investor-ready scale-ups wanting to raise between $250K and $10M are invited to apply.
VC4A is looking for up to 16 female founders who are heading innovative, high-growth scale-ups to pitch to a worldwide network of African investors. Do you have a business in Africa that is profitable and wants to fund between $250K and $10M? Application Deadline: May 27th, 2022.
VC4A is now accepting applications from women-led enterprises from around Africa. According to VC4A, the decision is based on the Africa: The Big Deal report, which claims that in 2021, 93 percent of Africa’s funding would go to firms run by male CEOs. Looking at the makeup of founding teams in 2021, a single man founder or a founding team with at least one male co-founder raised almost 99 percent of the investment.
VC4A claims, Companies participating in the program gain access to a curated investor network and are interviewed by top VC funds as part of the vetting process. Angel investors, VC fund managers, and corporates who engage in the program provide mentorship and technical support to the finalists. The Venture Showcase is a powerful tool for promoting your fundraising campaign and connecting with potential investors. Last but not least, this is an excellent opportunity to share and learn from your peers while also forming long-term bonds with them.
In 2017-2021, VC4A has selected 90 scale-ups as part of 6 showcase programs in emerging markets, resulting in a number of deals totaling over $400M. VC4A stated that, this is an exclusive opportunity to introduce your company to leading investors backing great startups from across Africa. So please don’t hesitate and start your application now!
Apply: 2022 VC4A Venture Showcase Africa – Women founder edition
DISCLAIMER
The opinions expresses here in the post "2022 VC4A Venture Showcase Africa – Women founder edition" are those of the individua's contributor(s) and do not necessarily reflect the views of Business Info Ethiopia , BIE Intelligence PLC, its publisher, editor, or any of its other contributors.